Nexben 100 mg Injection
  1. Home
  2. Pharma Products
  3. Celon Laboratories Ltd
  4. Nexben 100 mg Injection

Nexben 100 mg Injection

Nexben 100 mg Injection contains bendamustine hydrochloride 100 mg, an alkylating anticancer medicine used for certain blood cancers. It is administered by intravenous infusion under the supervision of a qualified healthcare professional. Bendamustine works by damaging the DNA of abnormal cells and inhibiting their growth.

BUY NOW

Category

Nexben 100 mg Injection is used in treatment protocols for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma. It may be used alone or in combination with other anticancer medicines according to the prescribed regimen. The dosage and treatment schedule are determined by the oncologist based on the patient’s condition and response to therapy. Regular monitoring is important during treatment because bendamustine can cause myelosuppression and other treatment-related effects.

Technical Specification

Specification Details
Active Ingredient Bendamustine Hydrochloride
Strength 100 mg
Dosage Form Injection
Route of Administration Intravenous
Pack Size 1 Vial
Manufacturer Celon Laboratories Pvt Ltd

Product Also Known As

Nexben 100 mg Injection, Nexben 100 Injection, Nexben Bendamustine Injection, Bendamustine 100 mg Injection, Bendamustine Hydrochloride Injection, Bendamustine Cancer Injection